2013 annual financial data
Summit Therapeutics 2013 Operating margin
Summit Therapeutics 2013 operating margin with verified reported values.
Direct answer
Operating margin was -363.83%.
Operating income was -6,709,000 GBP and net income was -6,093,000 GBP.
Operating cash flow was -9,680,984 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,844,000 GBP
- Operating income
- -6,709,000 GBP
- Net income
- -6,093,000 GBP
- Operating cash flow
- -9,680,984 GBP